Literature DB >> 20463083

Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells.

Elena Gorbunova1, Irina N Gavrilovskaya, Erich R Mackow.   

Abstract

Hantaviruses infect endothelial cells and cause 2 vascular permeability-based diseases. Pathogenic hantaviruses enhance the permeability of endothelial cells in response to vascular endothelial growth factor (VEGF). However, the mechanism by which hantaviruses hyperpermeabilize endothelial cells has not been defined. The paracellular permeability of endothelial cells is uniquely determined by the homophilic assembly of vascular endothelial cadherin (VE-cadherin) within adherens junctions, which is regulated by VEGF receptor-2 (VEGFR2) responses. Here, we investigated VEGFR2 phosphorylation and the internalization of VE-cadherin within endothelial cells infected by pathogenic Andes virus (ANDV) and Hantaan virus (HTNV) and nonpathogenic Tula virus (TULV) hantaviruses. We found that VEGF addition to ANDV- and HTNV-infected endothelial cells results in the hyperphosphorylation of VEGFR2, while TULV infection failed to increase VEGFR2 phosphorylation. Concomitant with the VEGFR2 hyperphosphorylation, VE-cadherin was internalized to intracellular vesicles within ANDV- or HTNV-, but not TULV-, infected endothelial cells. Addition of angiopoietin-1 (Ang-1) or sphingosine-1-phosphate (S1P) to ANDV- or HTNV-infected cells blocked VE-cadherin internalization in response to VEGF. These findings are consistent with the ability of Ang-1 and S1P to inhibit hantavirus-induced endothelial cell permeability. Our results suggest that pathogenic hantaviruses disrupt fluid barrier properties of endothelial cell adherens junctions by enhancing VEGFR2-VE-cadherin pathway responses which increase paracellular permeability. These results provide a pathway-specific mechanism for the enhanced permeability of hantavirus-infected endothelial cells and suggest that stabilizing VE-cadherin within adherens junctions is a primary target for regulating endothelial cell permeability during pathogenic hantavirus infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463083      PMCID: PMC2898267          DOI: 10.1128/JVI.00576-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  Endothelium as an organ system.

Authors:  William C Aird
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

2.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Clinical features of HFRS in Scandinavia as compared with East Asia.

Authors:  J Lähdevirta
Journal:  Scand J Infect Dis Suppl       Date:  1982

Review 4.  Endothelial cell barrier regulation by sphingosine 1-phosphate.

Authors:  Bryan J McVerry; Joe G N Garcia
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

5.  Hantaan virus infection of human endothelial cells.

Authors:  M N Pensiero; J B Sharefkin; C W Dieffenbach; J Hay
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group.

Authors:  J S Duchin; F T Koster; C J Peters; G L Simpson; B Tempest; S R Zaki; T G Ksiazek; P E Rollin; S Nichol; E T Umland
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

7.  Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent.

Authors:  K B Nolte; R M Feddersen; K Foucar; S R Zaki; F T Koster; D Madar; T L Merlin; P J McFeeley; E T Umland; R E Zumwalt
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

8.  Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

Authors:  S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

9.  Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta.

Authors:  Yihong Wang; Sergey Pampou; Koshi Fujikawa; Lyuba Varticovski
Journal:  J Cell Physiol       Date:  2004-01       Impact factor: 6.384

10.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.

Authors:  H F Dvorak; T M Sioussat; L F Brown; B Berse; J A Nagy; A Sotrel; E J Manseau; L Van de Water; D R Senger
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  43 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

2.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 3.  Virus interactions with endothelial cell receptors: implications for viral pathogenesis.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Curr Opin Virol       Date:  2014-07-24       Impact factor: 7.090

4.  Hantavirus interferon regulation and virulence determinants.

Authors:  Erich R Mackow; Nadine A Dalrymple; Velasco Cimica; Valery Matthys; Elena Gorbunova; Irina Gavrilovskaya
Journal:  Virus Res       Date:  2014-01-08       Impact factor: 3.303

5.  Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin.

Authors:  Punya Shrivastava-Ranjan; Pierre E Rollin; Christina F Spiropoulou
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

6.  The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction.

Authors:  Valery Matthys; Elena E Gorbunova; Irina N Gavrilovskaya; Timothy Pepini; Erich R Mackow
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Timothy Pepini; Erich R Mackow
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

8.  Protective effect of COMP-angiopoietin-1 on peritoneal vascular permeability and peritoneal transport function in uremic peritoneal dialysis rats.

Authors:  Yuanyuan Shi; Yifan Xiong; Yutian Lei; Zhenyuan Li; Hao Yan; Jiangzi Yuan; Feng Ding; Wei Fang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

9.  Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Erich R Mackow
Journal:  Antiviral Res       Date:  2013-05-20       Impact factor: 5.970

10.  Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.